Stock AMGN34 AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Amgen Inc. Sao Paulo

Equities

AMGN34

BRAMGNBDR004

Market Closed - Sao Paulo
Other stock markets
 15:29:55 2024-05-24 EDT 		5-day change 1st Jan Change
56.88 BRL +0.21% Intraday chart for Amgen Inc. -2.02% +13.87%
05-22 Sandoz: Marketing authorization for Wyost and Jubbonti in the EU CF
05-22 Roche Gets US FDA Breakthrough Designation For Lipoprotein(a) Test MT

Chart calendar Amgen Inc.

8a828d104.CPYZsvk_TKCeiRN34pXBqiZXR44Qflr8w3z0vMNrDB0.MLF09MhWIM_PzXUbreeR8HI5deNgDi6pgDKe0vIFYXs_xmHEkUUWlqbKSg~4722f7eb1899f8f768fabd9c8b744651

Upcoming events on Amgen Inc.

2024-05-31 14:00 Annual General Meeting
2024-07-29 Q2 2024 Earnings Release (Projected)
2024-10-28 Q3 2024 Earnings Release (Projected)
2025-02-03 Q4 2024 Earnings Release (Projected)
2025-04-30 Q1 2025 Earnings Release (Projected)

Past events on Amgen Inc.

2024-05-21 17:15 American Thoracic Society Conference - Reduced Mucus Plugging with Tezepelumab
2024-05-21 17:15 American Thoracic Society Conference - Asthma Exacerbation Rates as a Function
2024-05-21 14:30 American Thoracic Society Conference - Patient Characteristics and Treatment Patterns
2024-05-21 14:30 American Thoracic Society Conference - Effect of Tezepelumab on Exercise Tolerance
2024-05-21 14:30 American Thoracic Society Conference - Efficacy of Tezepelumab in Black or African American Patients
2024-05-21 14:30 American Thoracic Society Conference - Efficacy of Biologics for Reducing
2024-05-21 14:30 American Thoracic Society Conference - Effect of Biologics on Biomarkers
2024-05-21 14:30 American Thoracic Society Conference - Poster Session No. C34
2024-05-21 14:30 American Thoracic Society Conference - Poster Session No. C31
2024-05-20 16:00 American Thoracic Society Conference
2024-05-20 12:50 American Thoracic Society Conference - Session No. B13
2024-05-20 12:15 American Thoracic Society Conference
2024-05-19 17:15 American Thoracic Society Conference - Phase 1 Safety and Efficacy of AZD8630/AMG104
2024-05-19 17:15 American Thoracic Society Conference - Greater Exacerbation Reductions with Earlier Biologic Initiat
2024-05-19 17:15 American Thoracic Society Conference - Session No. A101
2024-05-19 12:15 American Thoracic Society Conference - Efficacy and Safety of Avacopan Versus
2024-05-14 12:20 Bank of America Merrill Lynch Global Healthcare Conference
2024-05-02 16:30 Q1 2024 Earnings Call
2024-05-02 16:01 Q1 2024 Earnings Release
2024-03-09 19:50 American Academy of Dermatology Meeting

Past dividends on Amgen Inc.

2024-05-15 Quarterly 2.25 USD
2024-02-14 Quarterly 2.25 USD
2023-11-15 Quarterly 2.13 USD
2023-08-16 Quarterly 2.13 USD
2023-05-16 Quarterly 2.13 USD
2023-02-13 Quarterly 2.13 USD
2022-11-15 Quarterly 1.94 USD
2022-08-16 Quarterly 1.94 USD
2022-05-15 Quarterly 1.94 USD
2022-02-13 Quarterly 1.94 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		23 362
23 196
0.71%		25 424
25 363
0.24%		25 979
25 999
-0.08%		26 323
26 247
0.29%		28 190
28 108
0.29%
33 001

EBITDA
Million USD		Released
Forecast
Spread 		13 363
13 029
2.56%		15 935
15 167
5.06%		15 822
16 002
-1.12%		16 178
15 935
1.53%		17 470
16 351
6.84%
18 668

EBIT
Million USD		Released
Forecast
Spread 		11 157
11 138
0.17%		12 334
12 315
0.15%		12 424
12 479
-0.44%		12 761
12 728
0.26%		13 399
13 423
-0.18%
14 768

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		9 138
9 499
-3.8%		8 133
8 782
-7.39%		6 701
6 379
5.04%		7 346
7 466
-1.6%		7 855
8 859
-11.33%
4 605

Net income
Million USD		Released
Forecast
Spread 		7 842
7 850
-0.1%		7 264
7 163
1.41%		5 893
5 598
5.27%		6 552
6 525
0.41%		6 717
7 401
-9.24%
4 133

EPS
USD		Released
Forecast
Spread 		12,9
12,8
0.4%		12,3
12,0
2.4%		10,3
9,84
4.5%		12,1
12,1
0.41%		12,5
13,8
-9.66%
7,93

Announcement Date30/01/2002/02/2107/02/2231/01/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		6 238
6 111
2.08%		6 594
6 526
1.04%		6 652
6 556
1.47%		6 839
6 766
1.08%		6 105
6 177
-1.17%		6 986
6 680
4.58%		6 903
6 948
-0.65%		8 196
8 106
1.11%		7 447
7 453
-0.08%
8 321


8 434


8 808


8 099


8 592

EBITDA
Million USD		Released
Forecast
Spread 		3 981
3 747
6.24%		4 163
3 953
5.31%		4 114
4 068
1.13%		3 920
3 744
4.7%		3 721
3 684
1.01%		4 411
4 152
6.25%		4 298
4 443
-3.25%		5 040
4 568
10.32%		4 477
4 373
2.37%
5 147


5 302


5 053







EBIT
Million USD		Released
Forecast
Spread 		3 140
2 939
6.84%		3 335
3 152
5.8%		3 277
3 201
2.39%		3 009
2 976
1.11%		2 821
2 879
-2.01%		3 515
3 292
6.77%		3 403
3 424
-0.62%		3 660
3 689
-0.78%		3 078
3 164
-2.71%
3 790


3 910


4 019


3 657


3 975

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		1 675
2 243
-25.32%		1 531
2 046
-25.18%		2 392
2 021
18.36%		1 748
1 866
-6.32%		3 442
2 294
50.04%		1 614
2 402
-32.81%		1 947
2 183
-10.81%		852
1 517
-43.85%		-68,0
1 214
-105.6%
1 558


1 584


1 539


2 599


2 985

Net income
Million USD		Released
Forecast
Spread 		1 476
1 725
-14.42%		1 317
1 749
-24.72%		2 143
1 665
28.68%		1 616
1 686
-4.16%		2 841
1 479
92.11%		1 379
1 840
-25.04%		1 730
1 772
-2.38%		767
1 308
-41.36%		-113
1 127
-110.03%
1 263


1 287


1 154


1 663


1 996

EPS
USD		Released
Forecast
Spread 		2,68
3,24
-17.27%		2,45
3,28
-25.3%		3,98
3,06
30.15%		3,00
3,21
-6.6%		5,28
2,98
77.12%		2,57
3,40
-24.34%		3,22
3,29
-2.1%		1,42
2,36
-39.72%		-0,21
2,71
-107.75%
2,50


2,74


2,50


3,11


3,74

Announcement Date27/04/2204/08/2203/11/2231/01/2327/04/2303/08/2331/10/2306/02/2402/05/24-----

Upcoming sector events for Amgen Inc.

2024-05-26 CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release
2024-05-26 NATCO PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-27 DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release
2024-05-28 IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-28 FDC LIMITED: Q4 2024 Earnings Release
2024-05-28 ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-28 PFIZER LIMITED: Q4 2024 Earnings Release
2024-05-29 ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release
2024-05-29 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-29 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
More events

Past sector events for Amgen Inc.

Today BLUE JET HEALTHCARE LIMITED: Q4 2024 Earnings Release
Today AUROBINDO PHARMA: Q4 2024 Earnings Release
Today DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release
2024-05-24 08:18 TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
2024-05-24 10:56 SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release
2024-05-23 10:47 ORCHID PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-23 06:45 SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release
2024-05-22 08:06 GLAND PHARMA LIMITED: Q4 2024 Earnings Release
2024-05-21 06:57 ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release
2024-05-20 17:00 TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. AMGN34 Stock
  5. Calendar Amgen Inc.